Articles published by Equillium, Inc.
![](https://mms.businesswire.com/media/20240806271893/en/2206875/22/1_Equillium_Logo_400x400.jpg)
![](https://mms.businesswire.com/media/20240718854113/en/2190242/22/1_Equillium_Logo_400x400.jpg)
![](https://mms.businesswire.com/media/20240702877165/en/2175218/22/1_Equillium_Logo_400x400.jpg)
![](https://mms.businesswire.com/media/20240612177757/en/2157497/22/1_Equillium_Logo_400x400.jpg)
Equillium to be included in the Russell Microcap® Index
June 12, 2024
From Equillium, Inc.
Via Business Wire
Tickers
EQ
![](https://mms.businesswire.com/media/20240605758743/en/2150970/22/1_Equillium_Logo_400x400.jpg)
![](https://mms.businesswire.com/media/20240529082041/en/2143196/22/1_Equillium_Logo_400x400.jpg)
![](https://mms.businesswire.com/media/20240514537675/en/2129590/22/1_Equillium_Logo_400x400.jpg)
![](https://mms.businesswire.com/media/20240507937807/en/2122201/22/1_Equillium_Logo_400x400.jpg)
![](https://mms.businesswire.com/media/20240403000593/en/2087633/22/1_Equillium_Logo_400x400.jpg)
![](https://mms.businesswire.com/media/20240401373328/en/2083802/22/1_Equillium_Logo_400x400.jpg)
![](https://mms.businesswire.com/media/20240325649617/en/2079308/22/1_Equillium_Logo_400x400.jpg)
Equillium Reports on Fourth Quarter and Full Year 2023 Financial Results and Corporate and Clinical Highlights
March 25, 2024
From Equillium, Inc.
Via Business Wire
Tickers
EQ
![](https://mms.businesswire.com/media/20240322517281/en/2076015/22/1_Equillium_Logo_400x400.jpg)
![](https://mms.businesswire.com/media/20231221688487/en/1976702/22/1_Equillium_Logo_400x400.jpg)
![](https://mms.businesswire.com/media/20231113802828/en/1942893/22/1_Equillium_Logo_400x400.jpg)
![](https://mms.businesswire.com/media/20231108064995/en/1938541/22/1_Equillium_Logo_400x400.jpg)
Equillium Reports Third Quarter 2023 Financial Results and Provides Corporate and Clinical Updates
November 08, 2023
From Equillium, Inc.
Via Business Wire
Tickers
EQ
![](https://mms.businesswire.com/media/20231106290948/en/1935231/22/1_Equillium_Logo_400x400.jpg)
![](https://mms.businesswire.com/media/20231003834264/en/1904664/22/1_Equillium_Logo_400x400.jpg)
Equillium to Host Analyst & Investor Day
October 03, 2023
From Equillium, Inc.
Via Business Wire
Tickers
EQ
![](https://mms.businesswire.com/media/20231002385530/en/1903407/22/1_Equillium_Logo_400x400.jpg)
Equillium to Present at the JonesTrading 2023 Healthcare Summit
October 02, 2023
From Equillium, Inc.
Via Business Wire
Tickers
EQ
![](https://mms.businesswire.com/media/20230920597056/en/1894676/22/1_Equillium_Logo_400x400.jpg)
Equillium to Present at the Cantor Fitzgerald Global Healthcare & LD Micro Main Event Conferences
September 20, 2023
From Equillium, Inc.
Via Business Wire
Tickers
EQ
![](https://mms.businesswire.com/media/20230830525918/en/1877850/22/1_Equillium_Logo_400x400.jpg)
![](https://mms.businesswire.com/media/20230809660222/en/1863676/22/1_Equillium_Logo_400x400.jpg)
Equillium Reports Second Quarter 2023 Financial Results and Provides Corporate and Clinical Updates
August 09, 2023
From Equillium, Inc.
Via Business Wire
Tickers
EQ
![](https://mms.businesswire.com/media/20230802747841/en/1857911/22/1_Equillium_Logo_400x400.jpg)
Equillium Announces $7.5 Million Share Repurchase Program
August 02, 2023
From Equillium, Inc.
Via Business Wire
Tickers
EQ
![](https://mms.businesswire.com/media/20230601005179/en/1807439/22/1_Equillium_Logo_400x400.jpg)
Equillium to Present at the Jefferies Global Healthcare & LD Micro Invitational Conferences
June 01, 2023
From Equillium, Inc.
Via Business Wire
Tickers
EQ
![](https://mms.businesswire.com/media/20230515005157/en/1792599/22/1_Equillium_Logo_400x400.jpg)
![](https://mms.businesswire.com/media/20230511005715/en/1791374/22/1_Equillium_Logo_400x400.jpg)
![](https://mms.businesswire.com/media/20230424005161/en/1771164/22/1_Equillium_Logo_400x400.jpg)
![](https://mms.businesswire.com/media/20230323005616/en/1746206/22/1_Equillium_Logo_400x400.jpg)
![](https://mms.businesswire.com/media/20230322005232/en/1744398/22/1_Equillium_Logo_400x400.jpg)
Equillium to Present at the H.C. Wainwright Autoimmune & Inflammatory Disease Conference
March 22, 2023
From Equillium, Inc.
Via Business Wire
Tickers
EQ
![](https://mms.businesswire.com/media/20230217005036/en/1716487/22/1_Equillium_Logo_400x400.jpg)
![](https://mms.businesswire.com/media/20230207005451/en/1706676/22/1_Equillium_Logo_400x400.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.